2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well

Apr.03.2025
2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well
Paris' Chinese wholesale market adapts to French disposable e-cigarette ban, shifts to compliant pod systems. Notable brands include JNR and FUMOT.

On February 25th, the ban on disposable e-cigarettes in France officially took effect. In order to understand the changes in the e-cigarette market in Paris after the ban, 2Firsts recently conducted field visits and research at the wholesale markets frequented by the Chinese community in Paris.

 

2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well
Display cabinet at the wholesale market of e-cigarettes for the Chinese community in Paris | Image source: 2Firsts

 

The customer base of the Chinese wholesale market consists mainly of Indian and Pakistani retailers and Chinese retail stores, which is quite different from the distribution channels of compliant pod systems (2ml products). Compliant pod systems are mainly sold through chain retail stores, tobacco channels, and gas stations, among other formal channels. Research has found that many wholesalers in the Chinese wholesale market have willingly stopped selling disposable e-cigarettes (2ml) and illegally oversized disposable e-cigarettes after the ban, and have actively shifted towards selling compliant market products. Currently, the main products being sold in this area are 2+10 products and high-capacity refillable products.

2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well
JNR's best-selling products in France | Image source: 2Firsts

 

In terms of product acceptance, the area has a relatively low acceptance of refill products. This is due to the refill products having a capacity of only 2ml, which is significantly less cost-effective compared to larger capacity refillable products and 2+10 products. This has made it difficult for wholesalers to effectively promote sales of the refill products.

2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well
Bestselling products from FUMOT in France | Image source: 2Firsts

 

In the large capacity oil injection market, FUMOT and JNR are the main brands. Currently, JNR has surpassed the former market leader FUMOT to become the top brand in the market and is facing shortages. It is worth noting that consumers have had almost no grace period after the ban was implemented, and there is a high level of acceptance for transitioning from non-compliant products to compliant products.

2Firsts Paris market research: disposable ban effective, large-capacity oil-fillable products sell well
Some merchants use images to show products to consumers | Image source: 2Firsts

 

Although all stores carry 2ml refillable products, their sales are extremely low. Some store owners are concerned about the risk of innovative products (such as 2+10 and large-capacity refillable options) being inspected, so they only provide them to consumers in picture form for selection.

 

Currently, disposable e-cigarettes have been completely banned from sale in Paris. However, some wholesalers from Afghanistan and the Middle East are still selling them openly. The Chinese black market has also largely achieved full compliance with regulations.

 

In addition, the police will conduct periodic inspections of wholesalers. Many wholesalers have reported a rapid decline in sales since the ban was implemented. However, they are optimistic about the prospects for large-capacity refillable products. Brands like JNR and Fumot have already obtained compliance qualifications, and as long as e-liquid is packaged separately, it can pass government inspections.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Philip Morris International (PMI) introduced TEREA Bold Red and Bold Black heated tobacco sticks in Germany in October 2026, both carrying a brand-rated tobacco-flavor intensity of 10, the highest level in the country's TEREA portfolio. Bold Red features leather and warm woody notes, while Bold Black combines woody and subtle floral notes. Both are sold in 20-stick packs at €8, approximately 2.6% above standard TEREA products. Germany's TEREA range now includes 11 flavor variants, alongside a separate 26-stick XL format priced at €10. IQOS Germany announced the new products on October 12, followed by a phased retail rollout from late October and an IQOS Club campaign running through December.
product
Nov.02
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07